Jyothy Labs Limited (JYOTHYLAB.BO)
INR 381.1
(-0.68%)
INR 381.1
(-0.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.15 Billion INR | -95.36% |
| 2022 | -591.16 Million INR | -162.08% |
| 2021 | 952.24 Million INR | 0.6% |
| 2020 | 946.53 Million INR | -70.47% |
| 2019 | 3.2 Billion INR | 56.9% |
| 2018 | 2.04 Billion INR | -57.51% |
| 2017 | 4.8 Billion INR | 5.12% |
| 2016 | 4.57 Billion INR | 6.74% |
| 2015 | 4.28 Billion INR | -21.25% |
| 2014 | 5.44 Billion INR | 9.42% |
| 2013 | 4.97 Billion INR | -18.03% |
| 2012 | 6.06 Billion INR | 16.19% |
| 2011 | 5.22 Billion INR | 1366.24% |
| 2010 | -412.35 Million INR | 62.29% |
| 2009 | -1.09 Billion INR | 0.0% |
| 2007 | -954.85 Million INR | -25.33% |
| 2006 | -761.85 Million INR | 40.3% |
| 2005 | -1.27 Billion INR | -43.18% |
| 2004 | -891.24 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | 100.0% |
| 2023 FY | -1.15 Billion INR | -95.36% |
| 2023 Q2 | -157.8 Million INR | 0.0% |
| 2023 Q4 | -1.15 Billion INR | 0.0% |
| 2023 Q3 | - INR | 100.0% |
| 2022 Q4 | -591.16 Million INR | 0.0% |
| 2022 Q2 | 523.5 Million INR | 0.0% |
| 2022 FY | -591.16 Million INR | -162.08% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 952.24 Million INR | 0.6% |
| 2021 Q2 | 751 Million INR | 0.0% |
| 2021 Q4 | 952.24 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q4 | 946.53 Million INR | 0.0% |
| 2020 FY | 946.53 Million INR | -70.47% |
| 2020 Q2 | 816 Million INR | 0.0% |
| 2019 Q4 | 3.2 Billion INR | 0.0% |
| 2019 FY | 3.2 Billion INR | 56.9% |
| 2019 Q2 | 1.93 Billion INR | 0.0% |
| 2018 FY | 2.04 Billion INR | -57.51% |
| 2018 Q4 | 2.04 Billion INR | 0.0% |
| 2017 FY | 4.8 Billion INR | 5.12% |
| 2017 Q4 | 4.8 Billion INR | 0.0% |
| 2017 Q2 | 910.9 Million INR | 0.0% |
| 2016 Q2 | -877 Million INR | 0.0% |
| 2016 FY | 4.57 Billion INR | 6.74% |
| 2016 Q4 | 4.57 Billion INR | 0.0% |
| 2015 Q4 | 4.28 Billion INR | 0.0% |
| 2015 FY | 4.28 Billion INR | -21.25% |
| 2015 Q2 | 3.81 Billion INR | 0.0% |
| 2014 Q4 | 5.44 Billion INR | 0.0% |
| 2014 FY | 5.44 Billion INR | 9.42% |
| 2014 Q2 | 4.74 Billion INR | 0.0% |
| 2013 FY | 4.97 Billion INR | -18.03% |
| 2013 Q4 | 4.97 Billion INR | 0.0% |
| 2012 FY | 6.06 Billion INR | 16.19% |
| 2011 FY | 5.22 Billion INR | 1366.24% |
| 2010 FY | -412.35 Million INR | 62.29% |
| 2009 FY | -1.09 Billion INR | 0.0% |
| 2007 FY | -954.85 Million INR | -25.33% |
| 2006 FY | -761.85 Million INR | 40.3% |
| 2005 FY | -1.27 Billion INR | -43.18% |
| 2004 FY | -891.24 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Ador Multiproducts Limited | 9.49 Million INR | 12268.37% |
| Ambica Agarbathies Aroma & Industries Limited | 658.93 Million INR | 275.268% |
| Bajaj Consumer Care Limited | -356.02 Million INR | -224.386% |
| Colgate-Palmolive (India) Limited | -13.02 Billion INR | 91.13% |
| Cupid Limited | -394.37 Million INR | -192.844% |
| Dabur India Limited | 6.98 Billion INR | 116.529% |
| Emami Limited | -1.07 Billion INR | -7.503% |
| Gillette India Limited | -4.75 Billion INR | 75.716% |
| Godrej Consumer Products Limited | 26.75 Billion INR | 104.317% |
| Hindustan Unilever Limited | -60.75 Billion INR | 98.099% |
| Hipolin Limited | 19.18 Million INR | 6119.493% |
| Honasa Consumer Limited | -3.54 Billion INR | 67.438% |
| JHS Svendgaard Laboratories Limited | -52.36 Million INR | -2105.649% |
| Kaya Limited | 2.83 Billion INR | 140.754% |
| Marico Limited | -4.15 Billion INR | 72.171% |
| N.K Industries Limited | -15.58 Million INR | -7308.429% |
| PAOS INDUSTRIES LIMITED | 163.57 Million INR | 806.046% |
| Paramount Cosmetics (India) Limited | 107.25 Million INR | 1176.82% |
| Pee Cee Cosma Sope Limited | 12.35 Million INR | 9450.66% |
| Procter & Gamble Hygiene and Health Care Limited | -5.85 Billion INR | 80.262% |